Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mesocel Collagen is an injectable collagen-based dermal filler developed by Dermaxshop for aesthetic and cosmetic procedures. As a biologic implant, it is primarily indicated for the correction of facial wrinkles, such as nasolabial folds, and for general soft tissue augmentation. The product works by providing immediate physical volume to the treated area and acting as a scaffold that supports tissue integration. Depending on the specific formulation, the collagen material may be resorbable, allowing for a temporary but significant aesthetic improvement. It is marketed globally to medical professionals and aesthetic practitioners for facial rejuvenation and volume restoration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mesocel Collagen.